Delara Babaie

Delara Babaie

Auto-generated profile, based on publicly available information

Delara Babaie

Department of Allergy and Clinical Immunology, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
JCJanet Chou
Janet Chou
WBWayne Bainter
Wayne Bainter
CPCraig D. Platt
Craig D. Platt
MTMahmood Tavassoli
Mahmood Tavassoli
AAAsghar Aghamohammadi
Asghar Aghamohammadi

9 October 2018 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
FKFatemeh Kiaee
Fatemeh Kiaee
MTMarzieh Tavakol
Marzieh Tavakol
ZCZahra Chavoshzadeh
Zahra Chavoshzadeh
SMSeyed Alireza Mahdaviani
Seyed Alireza Mahdaviani
AAAsghar Aghamohammadi
Asghar Aghamohammadi

1 December 2017 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
SAShirin Abbasi
Shirin Abbasi
MKMohammad Kamalinejad
Mohammad Kamalinejad
DBDelara Babaie
Delara Babaie
SSSeyedMohammad Shams
SeyedMohammad Shams
ZSZahra Sadr
Zahra Sadr
HRHassan Rakhshandeh
Hassan Rakhshandeh

14 October 2014 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SASaba Arshi
Saba Arshi
DBDelara Babaie
Delara Babaie
MNMohammad Nabavi
Mohammad Nabavi
MTMajid Tebianian
Majid Tebianian
BGBabak Ghalehbaghi
Babak Ghalehbaghi
RGReza Gholami
Reza Gholami

1 March 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
RYReza Yazdani
Reza Yazdani
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
FKFatemeh Kiaee
Fatemeh Kiaee
SHSima Habibi
Sima Habibi
GAGholamreza Azizi
Gholamreza Azizi
AAAsghar Aghamohammadi
Asghar Aghamohammadi

25 August 2016 in International Archives of Allergy and Immunology
Verified
Journal Article
Open access
PDF file
ZKZahra Karami
Zahra Karami
MMMehrnaz Mesdaghi
Mehrnaz Mesdaghi
PKParvaneh Karimzadeh
Parvaneh Karimzadeh
MMMahboubeh Mansouri
Mahboubeh Mansouri
MTMohammad Mehdi Taghdiri
Mohammad Mehdi Taghdiri
ZCZahra Chavoshzadeh
Zahra Chavoshzadeh
Background/Aim: Administration of the anticonvulsant drugs phenobarbital, phenytoin, carbamazepine and lamotrigine can be associated with severe hypersensitivity reactions. The lymphocyte transformation test (LTT) is a method to determine which drug has caused the hypersensitivity reaction. This study was done to evaluate the results of LTT in patients with delayed hypersensitivity reactions following the administration of anticonvulsants. Methods: Twenty-four patients with hypersensitivity reactions, e.g. drug-induced hypersensitivity syndrome/drug rash and eosinophilia with systemic symptoms (DIHS/DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN), following the administration of anticonvulsant drugs, and 24 patients who had used anticonvulsant drugs but did not have hypersensitivity reactions (the control group) were included in this study. Peripheral blood mononuclear cells were isolated. The cells were stimulated with the drugs, phytohemagglutinin as a mitogen and Candida as an antigen (positive controls). Lymphocyte proliferation was measured using the BrdU proliferation assay kit (Roche, Germany). The stimulation index was calculated as the mean ratio of the OD of stimulated cells divided by the OD of unstimulated cells. The results in the case and control groups were compared. Results: Of 24 patients in the test group, 14 (58.3%) had positive LTT results and 10 (41.7%) had negative results. Among patients in the control group, 1 (4.2%) had a positive LTT result and 23 (95.8%) had negative results. Among the patients who had received carbamazepine and phenytoin, there was a significant difference between the results of LTT in the case and control groups (p = 0.002 and p = 0.028, respectively). Although patients receiving lamotrigine and phenobarbital had more positive LTT results in the case group than in the control group, these differences were not statistically significant. The sensitivity, specificity, positive predictive value and negative predictive value of LTT were 58.4, 95.8, 93.3 and 69.9%, respectively. Conclusions: Considering the significant difference in LTT results between the case and control groups in patients receiving carbamazepine and phenytoin, and not observing such a difference in patients receiving phenobarbital and lamotrigine, LTT results are more valuable for the diagnosis of hypersensitivity reactions following the administration of carbamazepine and phenytoin. The LTT has good specificity but low sensitivity for the diagnosis of drug hypersensitivity reactions.